LEADER 01568nam0 22003253i 450 
001 VAN00271348
005 20240806101532.46
017 70$2N$a9783031345678
100   $a20240207d2023       |0itac50      ba
101   $aeng
102   $aCH
105   $a||||    |||||
200 1 $aRegulatory Aspects of Gene Therapy and Cell Therapy Products$eA Global Perspective$fMaria Cristina Galli editor
210   $aCham$cSpringer$d2023
215   $aIX, 242 p.$cill.$d24 cm
410  1$1001VAN00064096$12001 $aAdvances in Experimental Medicine and Biology$1210  $aNew York$cPlenum$d2003-$v1430
620   $aCH$dCham$3VANL001889
702  1$aGalli$bMaria C.$3VANV223002
712   $aSpringer <editore>$3VANV108073$4650
790  1$aGalli, Maria Cristina$zGalli, Maria C.$3VANV223003
790  1$aGalli, M. C.$zGalli, Maria C.$3VANV223004
790  1$aGalli, M.C.$zGalli, Maria C.$3VANV223005
801   $aIT$bSOL$c20240906$gRICA
856 4 $uhttps://link.springer.com/book/10.1007/978-3-031-34567-8$zE-book - Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth
899   $aBIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$1IT-CE0101$2VAN17
912   $fN
912   $aVAN00271348
950   $aBIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$d17CONS      e-book                  2309        $e17BIB2309/452  452     20240207            
996   $aRegulatory Aspects of Gene Therapy and Cell Therapy Products$92526666
997   $aUNICAMPANIA